In vitro study of BCX-34: a new human T-lymphocyte-specific purine phosphorylase inhibitor.
作者信息
Iwata H, Wada Y, Walsh M, Montgomery J A, Hirose H, Mendez R, Cicciarelli J, Iwaki Y
机构信息
Department of Urology, Metic Transplantation Laboratories, University of Southern California School of Medicine, Los Angeles 90057, USA.
出版信息
Transplant Proc. 1998 Jun;30(4):983-6. doi: 10.1016/s0041-1345(98)00119-5.
PMID:9636397
Abstract
摘要
相似文献
1
In vitro study of BCX-34: a new human T-lymphocyte-specific purine phosphorylase inhibitor.
Transplant Proc. 1998 Jun;30(4):983-6. doi: 10.1016/s0041-1345(98)00119-5.
2
Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells.新型嘌呤核苷磷酸化酶抑制剂BCX-34对正常人淋巴细胞激活和增殖的影响
Immunopharmacology. 1998 Jul;40(1):1-9. doi: 10.1016/s0162-3109(98)00012-5.
3
BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor.
Artif Organs. 1996 Aug;20(8):849-52. doi: 10.1111/j.1525-1594.1996.tb04557.x.
4
Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent.嘌呤核苷磷酸化酶抑制剂BCX-1777（免疫菌素-H）——一种新型强效口服活性免疫抑制剂。
Int Immunopharmacol. 2001 Jun;1(6):1199-210. doi: 10.1016/s1567-5769(01)00056-x.
5
In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP.嘌呤核苷磷酸化酶抑制剂BCX-34的体内和体外药理活性：GTP和dGTP的作用
Immunopharmacology. 1996 Oct;35(1):53-63. doi: 10.1016/0162-3109(96)00123-3.
6
Apoptotic death induced in MOLT-4 T-lymphoblasts by purine nucleoside phosphorylase inhibition.
Inflamm Res. 1997 Aug;46 Suppl 2:S151-2. doi: 10.1007/s000110050150.
7
PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR).
Agents Actions. 1993;39 Spec No:C96-8. doi: 10.1007/BF01972732.
8
Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes--a novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies.强效口服生物可利用嘌呤核苷磷酸化酶抑制剂 BCX-4208 诱导 B 和 T 淋巴细胞凋亡——一种用于自身免疫性疾病、器官移植和血液系统恶性肿瘤的新型治疗方法。
Int Immunopharmacol. 2010 Jul;10(7):784-90. doi: 10.1016/j.intimp.2010.04.009. Epub 2010 Apr 22.
9
In vitro immunosuppressive effect of 8-amino-9-benzylguanine on lymphocytes.
Transplant Proc. 1994 Aug;26(4):1910-2.
10
The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor.
Inflamm Res. 1995 Aug;44 Suppl 2:S181-2. doi: 10.1007/BF01778321.
Zotero 插件